Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.
Identifieur interne : 001F40 ( PubMed/Corpus ); précédent : 001F39; suivant : 001F41Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.
Auteurs : C. Boneti ; B. Badgwell ; Y. Robertson ; S. Korourian ; L. Adkins ; V. KlimbergSource :
- Minerva ginecologica [ 0026-4784 ] ; 2012.
English descriptors
- KwdEn :
- MESH :
- adverse effects : Lymph Node Excision.
- etiology : Lymphedema.
- methods : Lymph Node Excision.
- pathology : Breast Neoplasms, Lymphedema.
- prevention & control : Lymphedema.
- surgery : Breast Neoplasms.
- Axilla, Female, Follow-Up Studies, Humans, Middle Aged, Prospective Studies.
Abstract
Axillary reverse mapping (ARM) is unproven in preventing lymphedema. The purpose of this study is to evaluate lymphedema rates with ARM added to lymphadenectomy.
PubMed: 23018481
Links to Exploration step
pubmed:23018481Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.</title><author><name sortKey="Boneti, C" sort="Boneti, C" uniqKey="Boneti C" first="C" last="Boneti">C. Boneti</name><affiliation><nlm:affiliation>University of Arkansas for Medical Sciences, Little Rock, AR, USA. boneticristiano@uams.edu</nlm:affiliation></affiliation></author><author><name sortKey="Badgwell, B" sort="Badgwell, B" uniqKey="Badgwell B" first="B" last="Badgwell">B. Badgwell</name></author><author><name sortKey="Robertson, Y" sort="Robertson, Y" uniqKey="Robertson Y" first="Y" last="Robertson">Y. Robertson</name></author><author><name sortKey="Korourian, S" sort="Korourian, S" uniqKey="Korourian S" first="S" last="Korourian">S. Korourian</name></author><author><name sortKey="Adkins, L" sort="Adkins, L" uniqKey="Adkins L" first="L" last="Adkins">L. Adkins</name></author><author><name sortKey="Klimberg, V" sort="Klimberg, V" uniqKey="Klimberg V" first="V" last="Klimberg">V. Klimberg</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23018481</idno><idno type="pmid">23018481</idno><idno type="wicri:Area/PubMed/Corpus">001F40</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F40</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.</title><author><name sortKey="Boneti, C" sort="Boneti, C" uniqKey="Boneti C" first="C" last="Boneti">C. Boneti</name><affiliation><nlm:affiliation>University of Arkansas for Medical Sciences, Little Rock, AR, USA. boneticristiano@uams.edu</nlm:affiliation></affiliation></author><author><name sortKey="Badgwell, B" sort="Badgwell, B" uniqKey="Badgwell B" first="B" last="Badgwell">B. Badgwell</name></author><author><name sortKey="Robertson, Y" sort="Robertson, Y" uniqKey="Robertson Y" first="Y" last="Robertson">Y. Robertson</name></author><author><name sortKey="Korourian, S" sort="Korourian, S" uniqKey="Korourian S" first="S" last="Korourian">S. Korourian</name></author><author><name sortKey="Adkins, L" sort="Adkins, L" uniqKey="Adkins L" first="L" last="Adkins">L. Adkins</name></author><author><name sortKey="Klimberg, V" sort="Klimberg, V" uniqKey="Klimberg V" first="V" last="Klimberg">V. Klimberg</name></author></analytic><series><title level="j">Minerva ginecologica</title><idno type="ISSN">0026-4784</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Axilla</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymph Node Excision (methods)</term><term>Lymphedema (etiology)</term><term>Lymphedema (pathology)</term><term>Lymphedema (prevention & control)</term><term>Middle Aged</term><term>Prospective Studies</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Axilla</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Middle Aged</term><term>Prospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Axillary reverse mapping (ARM) is unproven in preventing lymphedema. The purpose of this study is to evaluate lymphedema rates with ARM added to lymphadenectomy.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23018481</PMID><DateCreated><Year>2012</Year><Month>09</Month><Day>28</Day></DateCreated><DateCompleted><Year>2012</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2012</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0026-4784</ISSN><JournalIssue CitedMedium="Print"><Volume>64</Volume><Issue>5</Issue><PubDate><Year>2012</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Minerva ginecologica</Title><ISOAbbreviation>Minerva Ginecol</ISOAbbreviation></Journal><ArticleTitle>Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.</ArticleTitle><Pagination><MedlinePgn>421-30</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Axillary reverse mapping (ARM) is unproven in preventing lymphedema. The purpose of this study is to evaluate lymphedema rates with ARM added to lymphadenectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this IRB approved study, 156 cases of SLNB/ALND from May 2007 to March 2010 were prospectively accrued to the study. Patients with an increase in arm volume greater than 20% over the contralateral side were considered to have lymphedema. Data was collected on identification and variations in lymphatic drainage, nodal status, ARM lymphatics preservation rate, adjuvant treatment (XRT, chemo) and lymphedema rate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">114 patients underwent SLNB only and 42 patients underwent ALND after SLNB, with a SLN identification rate of 100%. Median age was 56.9(±12.5) and BMI was 29.4(±6.9). Mean follow up was 14.6±9.4 months. ARM lymphatics were near or in the SLN field in 45/114 (39%) of the SLNB cases and in 34/42 (81%) of the ALND. ARM nodes were preserved in 92.3% of the cases (144/156). A total of 12 ARM nodes were resected because of crossover or suspicious appearance. The 2 ARM nodes involved by malignancy were in heavily positive axilla (>5 positive nodes). Lymphedema was diagnosed in 3.5% (4/114) of the SLNB cases and 7%(3/42) of the combined SLNB+ALND cases. 2.9% (4/140) of the patients who had the ARM lymphatics preserved and 18.7%(3/16) who had it transected developed clinical lymphedema. No regional recurrences were seen.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Preserving the ARM nodes is safe and resulted in a low incidence of postoperative lymphedema after SLNB and ALND.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boneti</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Arkansas for Medical Sciences, Little Rock, AR, USA. boneticristiano@uams.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badgwell</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Korourian</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Adkins</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Klimberg</LastName><ForeName>V</ForeName><Initials>V</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Ginecol</MedlineTA><NlmUniqueID>0400731</NlmUniqueID><ISSNLinking>0026-4784</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23018481</ArticleId><ArticleId IdType="pii">R09123352</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F40 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001F40 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23018481
|texte= Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23018481" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |